Delex Pharma has announced a new distributorship agreement with Verathon to market its advanced and. Innovative video laryngoscopes GLIDESCOPE GO, including the GlideScope Titanium Reusable and GlideScope Spectrum Single-use models.
Verathon, as Delex Pharma’s esteemed strategic partner, is renowned for its 40 years of innovation and excellence in the medical field, consistently delivering high-quality products and services to its global network of partners. This partnership represents the pinnacle of Delex’s commitment to advancing medical technology in the country.
Verathon is a global leader in medical devices, dedicated to being a trusted partner for its customers by providing durable, high-quality products that offer lasting clinical and economic value. The company has made significant advancements in patient care, particularly in airway management and bladder volume measurement, establishing itself as the market leader in both areas. Verathon’s innovative GlideScope video laryngoscopy and BFlex bronchoscopy solutions, along with its BladderScan portable ultrasound devices, effectively meet the needs of healthcare professionals. A subsidiary of Roper Technologies, Verathon is headquartered in Bothell, Washington, with subsidiaries in Canada, Europe, and Asia.
Recent studies have highlighted video-assisted laryngoscopy as the new gold standard for emergency airway management, significantly improving first-pass success rates. This cutting-edge technology is increasingly utilized in anesthesiology, critical care, and emergency medicine, where reliability is paramount.
In line with Delex’s goal to provide exceptional service to healthcare providers, fulfilling its quality objectives as an ISO 9001:2015-certified company, Delex Pharma organized an extensive training session for its medical representatives on July 19, 2024. Facilitated by experts from Verathon, the training was designed to equip the company’s medical device team with the necessary skills and knowledge to promote and support the GlideScope technology effectively. This initiative underscores Delex Pharma’s dedication to accelerating its expertise and ensuring healthcare professionals receive the best possible service.
The innovative features of the GlideScope have already caught the attention of two of the country’s leading tertiary hospitals, St. Luke’s Medical Center and Asian Hospital and Medical Center, which have procured these advanced devices for their clinical use. This adoption by prestigious institutions is a testament to the trust and confidence in Delex Pharma’s cutting-edge medical solutions.
Delex Pharma’s strategic partnership with Verathon is part of its broader plan to expand its medical device business. Delex Pharma’s medical device division, which was established in 2015, initially introduced the CADD-Solis infusion systems from Smiths Medical. Over the years, the company has diversified its portfolio by incorporating Ultrasound for Cardiology from Philips and Neutraclear needless connectors manufactured by CAIR LGL. These expansions reflect Delex Pharma’s commitment to bringing diverse and innovative medical technologies to the market.
BNCM is an Asset Management Company that secures its assets by investing in companies with strong growth potentials, robust revenues, significant profits, proven track records, and promising business models with highly experienced management teams that will exceptionally qualify for quotation and or listing on the OTC and or NASDAQ Market within the next 2 to 3 years. The growth of these companies will directly provide more employment opportunities to the communities, improve the country’s economy, and bring greater social change to humanity.
For more information, visit: https://www.bncm.net/
DELEX is a Delaware-registered company, and a holding company of DLX Holdings, Inc. (DLX). DLX is a Philippine-based parent company that holds a 60% controlling interest in Delex Pharma International, Inc. an ISO 9001-2015 Certified company, and a controlling interest in JMN Brother’s Pharma Limited, Inc. and MD Pharma, Inc. DLX and its subsidiaries are involved in the development and distribution of pharmaceutical and healthcare products in the Philippines.
For more information, visit: https://delexhealth.com/
